Relay Therapeutics, Inc. announced that it has entered into a securities purchase agreement to issue 2,500,000 shares at a price of $12 per share for the gross proceeds of $30 million on January 8, 2024. The transaction will include participation from new investor, Nextech. The transaction is expected to close on January 10, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.51 USD | -3.41% | -2.25% | -40.87% |
06/05 | Oppenheimer Adjusts Relay Therapeutics Price Target to $25 From $33, Maintains Outperform Rating | MT |
02/05 | Earnings Flash (RLAY) RELAY THERAPEUTICS Reports Q1 Revenue $10M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.87% | 864M | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- RLAY Stock
- News Relay Therapeutics, Inc.
- Relay Therapeutics, Inc. announced that it expects to receive $30 million in funding